Curing cancer is something we all want to do, but logistical issues remain around translating that into practice, explained Sigrun Hallmeyer, MD, medical oncologist with Advocate Health.
In this interview with The American Journal of Managed Care®, Sigrun Hallmeyer, MD, medical oncologist with Advocate Health, addresses logistical holdups in precision medicine that may be preventing all patients who need this care from being able to access it. Among the top issues are inappropriate care and wasteful health care spend.
Transcript
Can you discuss potential policy priorities to increase equitable access to health care?
Curing cancer is, of course, the headline—that's what we're all wanting to do. But where we sort of ail and have an issue with is the logistics of how do you translate that. Precision medicine certainly plays a huge role in that, and health equity plays a huge role in that because access to care is one big problem that we have in this country. Another big problem, which I think is equally large, is that we have a lot of waste within our system. I would say probably a good third of our health care dollar is stuck in our system because we duplicate care, or we have care that is inappropriate, too late or early, wrong, whatever. With all that, we need to become better in becoming efficient and automated.
The utilization of appropriate discussion of precision medicine or personalized care should not be a boutique situation that is only offered to wealthy, highly educated patients who have the resources to come to the oncologist and ask for it. Or conversely, for patients who are seen in higher-level centers of care where the physicians are familiar with the precision medicine approach and have the logistical background that I discussed earlier, where you have all the pieces in place where such tests can actually lead to an impact on their care.
And so what I think would probably be the very best sort of societal approach to equity in care would be that we need to find a way to reflex these type of things. Very simply put, if you have, say, a lung cancer diagnosis, it shouldn't matter if you're diagnosed in South Chicago, or at MD Anderson in Houston, or at Sloan Kettering in New York City. Your specimen should be reflexively tested for targetable mutations and the patient and the physician should be equally enabled to use that information to define a targeted or precision medicine approach to their therapy.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More